Annika Tulenheimo-Silfvast

Learn More
Objective: This study was initiated as a consequence of a clinical observation in one hospital of several endometrial carcinomas among users of a fixed combination of a 3-month cycle oral hormonal replacement therapy (HRT), which has been marketed in Finland since 1990. We studied whether the use of 3-month (“long”) cycle HRT is accompanied by a higher risk(More)
  • 1